<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medbio</journal-id><journal-title-group><journal-title xml:lang="ru">Медико-биологические проблемы жизнедеятельности</journal-title><trans-title-group xml:lang="en"><trans-title>Medical and Biological Problems of Life Activity</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2088</issn><publisher><publisher-name>Республиканский научно-практический центр радиационной медицины и экологии человека</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medbio-113</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Клинико-иммунологические и генетические особенности пациентов с атопическим дерматитом</article-title><trans-title-group xml:lang="en"><trans-title>Clinical, immunological and genetic characteristics in patients with atopic dermatitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыблева</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zybleva</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Силин</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Silin</surname><given-names>A. E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сердюкова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Serdyukova</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихонова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Tihonova</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ «РНПЦ радиационной медицины и экологии человека», г. Гомель, Беларусь</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>02</day><month>03</month><year>2023</year></pub-date><volume>0</volume><issue>2</issue><fpage>89</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зыблева С.В., Силин А.Е., Сердюкова О.А., Тихонова Е.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Зыблева С.В., Силин А.Е., Сердюкова О.А., Тихонова Е.С.</copyright-holder><copyright-holder xml:lang="en">Zybleva S.V., Silin A.E., Serdyukova O.A., Tihonova E.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medbio.ejournal.by/jour/article/view/113">https://medbio.ejournal.by/jour/article/view/113</self-uri><abstract><p>Обследовано 155 пациентов с атопическим дерматитом, разделенные на 2 группы: 1 группа (АД1) - 123 человека с сопутствующей респираторной аллергией (бронхиальная астма, аллергический ринит, поллиноз), 2 группа (АД2) - 32 человека без сопутствующей респираторной аллергии. Мутации гена FLG были выявлены у 13 пациентов с атопическим дерматитом (14,61%) и у 3 человек из группы сравнения (5,77%) (отношения шансов 2,83). В группе АД было выявлено статистически значимое снижение уровня моноцитов, экспрессирующих CD18+и CD11a+ рецепторы. Уровень нейтрофилов, экспрессирующих рецептор CD11c+, также был снижен в группе пациентов с атопическим дерматитом. По частоте респираторной патологии группы пациентов с наличием и отсутствием мутаций значимо различались: в группе с мутацией гена FLG частота респираторной патологии была значимо выше (p=0,001; Fisher exact, two-tailed). Сравнение групп пациентов по наличию IgE, специфических к респираторным аллергенам, показало, что в группе с наличием мутации FLG сенсибилизация к аллергенам домашней пыли и эпидермальным аллергенам животных встречалась статистически значимо чаще. По частоте выявления IgE, специфических к аллергенам пыльцы злаков и пыльце диких трав, сенсибилизация значимо чаще была в группе без наличия мутации FLG. Таким образом, при лечении пациентов с атопическим дерматитом необходимо учитывать возможность наличия мутаций в гене FLG и уделять пристальное внимание мероприятиям, направленным на элиминацию аллергенов домашней пыли и особенно аллергенов эпидермиса домашних животных.</p></abstract><trans-abstract xml:lang="en"><p>We examined 155 patients with atopic dermatitis and divided them into two groups: Group 1 (AD1) - 123 patients with concomitant respiratory allergies (bronchial asthma, allergic rhinitis, pollinosis), group 2 (AD2) - 32 patients without concomitant respiratory allergies. Mutations in the FLG gene were detected in 13 patients with atopic dermatitis (14,61%) and in 3 patients from the comparison group (5,77%) (odds ratio 2,83).In the AD group, a statistically significant decrease in the level of monocytes expressing CD18+ and CD11a+ receptors was revealed. The level of neutrophils expressing the CD11c+ receptor also decreased in the group of patients with atopic dermatitis.In terms of the frequency of respiratory pathology, the groups of patients with and without mutations differed significantly: in the group with the FLG gene mutation, the frequency of respiratory pathology was significantly higher (p = 0,001; Fisher exact, two-tailed). Comparison of groups of patients for the presence of specific IgE to respiratory allergens showed that in the group with the FLG mutation, sensitization to house dust allergens and epidermal allergens of animals was statistically significantly more frequent. According to the frequency of detecting specific IgE to allergens of cereal pollen and wild grass pollen, sensitization was significantly more frequent in the group without the FLG mutation. Thus, when treating patients with atopic dermatitis, it is necessary to take into account the possibility of mutations in the FLG gene and pay close attention to measures aimed at eliminating house dust allergens and especially the epidermal allergen of domestic animals.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>рецепторы адгезии</kwd><kwd>мутация FLG</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>adhesion receptors</kwd><kwd>FLG mutation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Novak, N. Advances in atopic dermatitis / N. Novak, D.Y. Leung // CurrOpinImmunol. - 2011. - Vol. 23, № 6. - Р. 778-783.</mixed-citation><mixed-citation xml:lang="en">Novak, N. Advances in atopic dermatitis / N. Novak, D.Y. Leung // CurrOpinImmunol. - 2011. - Vol. 23, № 6. - Р. 778-783.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations / S. Weidinger [et al.] // J Allergy ClinImmunol. - 2006. - Vol. 118, № 1. - Р. 214-219.</mixed-citation><mixed-citation xml:lang="en">Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations / S. Weidinger [et al.] // J Allergy ClinImmunol. - 2006. - Vol. 118, № 1. - Р. 214-219.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis / T. Nomura [et al.] // J Allergy ClinImmunol. - 2007. - Vol. 119, № 2. -Р. 434-440.</mixed-citation><mixed-citation xml:lang="en">Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis / T. Nomura [et al.] // J Allergy ClinImmunol. - 2007. - Vol. 119, № 2. -Р. 434-440.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin / L. Kolbe [et al.] // Skin Res Technol. - 2001. - Vol. 7, № 2. - Р. 73-77.</mixed-citation><mixed-citation xml:lang="en">Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin / L. Kolbe [et al.] // Skin Res Technol. - 2001. - Vol. 7, № 2. - Р. 73-77.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Severity Correlates with Impaired Barrier in Filaggrin-Related Eczema / I. Nemoto-Hasebe [et al.] // Journal of Investigative Dermatology. - 2009. - Vol. 129, № 3. - Р. 682-689.</mixed-citation><mixed-citation xml:lang="en">Clinical Severity Correlates with Impaired Barrier in Filaggrin-Related Eczema / I. Nemoto-Hasebe [et al.] // Journal of Investigative Dermatology. - 2009. - Vol. 129, № 3. - Р. 682-689.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Киндеева, Е.Т. Функциональное состояние кожного барьера у детей с атопическим дерматитом / Е.Т. Киндеева, Е.Е. Варламов, А.Н. Пампура // Росаллергологический журн. - 2013. - Т. 1. - С. 52-57.</mixed-citation><mixed-citation xml:lang="en">Киндеева, Е.Т. Функциональное состояние кожного барьера у детей с атопическим дерматитом / Е.Т. Киндеева, Е.Е. Варламов, А.Н. Пампура // Росаллергологический журн. - 2013. - Т. 1. - С. 52-57.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Catherine, D. The role of filaggrin in atopic dermatitis and allergic disease / D. Catherine, D.I. Alan // Annals of Allergy Asthma &amp; Immunology. - 2020. - Vol. 124, №1. - P. 36-43.</mixed-citation><mixed-citation xml:lang="en">Catherine, D. The role of filaggrin in atopic dermatitis and allergic disease / D. Catherine, D.I. Alan // Annals of Allergy Asthma &amp; Immunology. - 2020. - Vol. 124, №1. - P. 36-43.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data / H.I. Baurecht [et al.] // J Allergy ClinImmunol. - 2007. - Vol. 120. - P. 1406- 1412.</mixed-citation><mixed-citation xml:lang="en">Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data / H.I. Baurecht [et al.] // J Allergy ClinImmunol. - 2007. - Vol. 120. - P. 1406- 1412.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Van den Oord, R.A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis / R.A. van den Oord, A. Sheikh // Br Med J. - 2009. - Vol. 339. - P. 2433.</mixed-citation><mixed-citation xml:lang="en">Van den Oord, R.A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis / R.A. van den Oord, A. Sheikh // Br Med J. - 2009. - Vol. 339. - P. 2433.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maternal filaggrin mutations increase the risk of atopic dermatitis in children: an effect independent of mutation inheritance /j. Esparza-Gordillo [et al.] // PLoS Genet. - 2015. -Vol. 11, №3. - P. 11e1005076.</mixed-citation><mixed-citation xml:lang="en">Maternal filaggrin mutations increase the risk of atopic dermatitis in children: an effect independent of mutation inheritance /j. Esparza-Gordillo [et al.] // PLoS Genet. - 2015. -Vol. 11, №3. - P. 11e1005076.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Atopic dermatitis endotypes and implications for targeted therapeutics / T. Czarnowicki [et al.] // J Allergy ClinImmunol. - 2019. - Vol. 143. - P. 1-11.</mixed-citation><mixed-citation xml:lang="en">Atopic dermatitis endotypes and implications for targeted therapeutics / T. Czarnowicki [et al.] // J Allergy ClinImmunol. - 2019. - Vol. 143. - P. 1-11.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts / L. Paternoster [et al.] // J Allergy ClinImmunol. - 2018. - Vol. 141. - P. 964-971.</mixed-citation><mixed-citation xml:lang="en">Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts / L. Paternoster [et al.] // J Allergy ClinImmunol. - 2018. - Vol. 141. - P. 964-971.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum / P.S. Gao [et al.] // J Allergy ClinImmunol. - 2009. - Vol. 124. - P. 507-513.</mixed-citation><mixed-citation xml:lang="en">Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum / P.S. Gao [et al.] // J Allergy ClinImmunol. - 2009. - Vol. 124. - P. 507-513.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations / S. Weidinger [et al.] // J AllergyClinImmunol. - 2006. -Vol. 118. - P. 214-219.</mixed-citation><mixed-citation xml:lang="en">Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations / S. Weidinger [et al.] // J AllergyClinImmunol. - 2006. -Vol. 118. - P. 214-219.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study /j.Henderson [et al.] // J Allergy ClinImmunol. - 2008. - Vol. 121. - P. 872-877.</mixed-citation><mixed-citation xml:lang="en">The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study /j.Henderson [et al.] // J Allergy ClinImmunol. - 2008. - Vol. 121. - P. 872-877.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Irvine, A.D. Fleshing out filaggrin phenotypes / A.D. Irvine // J Invest Dermatol. - 2007. - Vol. 127. - P. 504-507.</mixed-citation><mixed-citation xml:lang="en">Irvine, A.D. Fleshing out filaggrin phenotypes / A.D. Irvine // J Invest Dermatol. - 2007. - Vol. 127. - P. 504-507.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Spergel, J.M. Atopic dermatitis and the atopic march /j.M. Spergel, A.S. Paller// J Allergy ClinImmunol. - 2003. - Vol. 112. - P.118-127.</mixed-citation><mixed-citation xml:lang="en">Spergel, J.M. Atopic dermatitis and the atopic march /j.M. Spergel, A.S. Paller// J Allergy ClinImmunol. - 2003. - Vol. 112. - P.118-127.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Filaggrin null mutations are associated with altered circulating Tregs in atopic dermatitis / V. Moosbrugger-Martinz [et al.] // J Cell Mol Med. - 2019. - Vol. 23. - P. 1288-1299.</mixed-citation><mixed-citation xml:lang="en">Filaggrin null mutations are associated with altered circulating Tregs in atopic dermatitis / V. Moosbrugger-Martinz [et al.] // J Cell Mol Med. - 2019. - Vol. 23. - P. 1288-1299.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells / C.S. Leitch [et al.] // J Allergy ClinImmunol. - 2016. - Vol. 138. - P. 482-490.</mixed-citation><mixed-citation xml:lang="en">Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells / C.S. Leitch [et al.] // J Allergy ClinImmunol. - 2016. - Vol. 138. - P. 482-490.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Consensus Conference on Pediatric Atopic Dermatitis / L.F. Eichenfield [et al.] // J Am AcadDermatol. - 2003. - Vol. 49, № 6. - P. 1088-1095.</mixed-citation><mixed-citation xml:lang="en">Consensus Conference on Pediatric Atopic Dermatitis / L.F. Eichenfield [et al.] // J Am AcadDermatol. - 2003. - Vol. 49, № 6. - P. 1088-1095.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Хаитов, Р.М. Физиология иммунитета: Обзор литературы / Р.М. Хаитов // Аллергия, астма и клинич. иммунология. - 2000. - № 2. - С. 3-16.</mixed-citation><mixed-citation xml:lang="en">Хаитов, Р.М. Физиология иммунитета: Обзор литературы / Р.М. Хаитов // Аллергия, астма и клинич. иммунология. - 2000. - № 2. - С. 3-16.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gene-Environment Interaction in the Onset of Eczema in Infancy: Filaggrin Loss- of-Function Mutations Enhanced by Neonatal Cat Exposure / H. Bisgaard [et al.] // PLoS Medicine. - 2008. - Vol. 5, № 6. - P. 131.</mixed-citation><mixed-citation xml:lang="en">Gene-Environment Interaction in the Onset of Eczema in Infancy: Filaggrin Loss- of-Function Mutations Enhanced by Neonatal Cat Exposure / H. Bisgaard [et al.] // PLoS Medicine. - 2008. - Vol. 5, № 6. - P. 131.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study /j. Henderson [et al.] // J Allergy ClinImmunol. - 2008. - Vol. 121, №4. - P. 872-877.</mixed-citation><mixed-citation xml:lang="en">The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study /j. Henderson [et al.] // J Allergy ClinImmunol. - 2008. - Vol. 121, №4. - P. 872-877.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
